The funding discussions point to investor interest in applying AI to make breakthroughs in life sciences.
from TechCrunch https://ift.tt/rv38lNc
Tuesday, July 14, 2026
OpenAI researcher Miles Wang in talks to launch AI drug discovery startup valued at $2B
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment